Dearborn Partners LLC trimmed its position in shares of STERIS plc (NYSE:STE – Free Report) by 3.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 114,224 shares of the medical equipment provider’s stock after selling 3,997 shares during the quarter. STERIS accounts for about 1.4% of Dearborn Partners LLC’s holdings, making the stock its 28th largest holding. Dearborn Partners LLC’s holdings in STERIS were worth $28,958,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently modified their holdings of the company. Board of the Pension Protection Fund purchased a new position in shares of STERIS during the 4th quarter valued at about $25,000. Activest Wealth Management boosted its holdings in STERIS by 423.8% during the 4th quarter. Activest Wealth Management now owns 110 shares of the medical equipment provider’s stock valued at $28,000 after acquiring an additional 89 shares during the period. Measured Wealth Private Client Group LLC purchased a new stake in STERIS during the 4th quarter valued at about $28,000. Harbor Investment Advisory LLC boosted its holdings in STERIS by 115.4% during the 4th quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock valued at $28,000 after acquiring an additional 60 shares during the period. Finally, Cornerstone Planning Group LLC boosted its holdings in STERIS by 342.3% during the 4th quarter. Cornerstone Planning Group LLC now owns 115 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 89 shares during the period. 94.69% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several brokerages recently weighed in on STE. Wall Street Zen cut STERIS from a “strong-buy” rating to a “buy” rating in a report on Saturday. KeyCorp dropped their target price on STERIS from $291.00 to $269.00 and set an “overweight” rating for the company in a report on Wednesday, May 13th. Weiss Ratings cut STERIS from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, May 27th. Finally, Piper Sandler restated an “overweight” rating and set a $270.00 target price on shares of STERIS in a report on Thursday, May 21st. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $278.00.
STERIS Trading Down 0.1%
STE opened at $212.13 on Friday. The business has a 50 day simple moving average of $217.24 and a two-hundred day simple moving average of $239.09. The firm has a market capitalization of $20.70 billion, a price-to-earnings ratio of 26.75 and a beta of 0.93. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.09 and a quick ratio of 1.54. STERIS plc has a one year low of $195.14 and a one year high of $269.44.
STERIS (NYSE:STE – Get Free Report) last released its quarterly earnings results on Monday, May 11th. The medical equipment provider reported $2.83 EPS for the quarter, missing analysts’ consensus estimates of $2.86 by ($0.03). The business had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.59 billion. STERIS had a net margin of 13.18% and a return on equity of 14.15%. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the previous year, the company earned $2.74 EPS. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. Analysts predict that STERIS plc will post 11.18 EPS for the current year.
STERIS Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 8th will be given a dividend of $0.63 per share. The ex-dividend date of this dividend is Monday, June 8th. This represents a $2.52 dividend on an annualized basis and a yield of 1.2%. STERIS’s dividend payout ratio is presently 31.78%.
Insider Buying and Selling
In other STERIS news, Director Richard C. Breeden sold 1,481 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $209.51, for a total transaction of $310,284.31. Following the completion of the transaction, the director owned 38,964 shares of the company’s stock, valued at $8,163,347.64. This represents a 3.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 1.07% of the stock is owned by insiders.
STERIS Company Profile
STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.
Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.
Read More
- Five stocks we like better than STERIS
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.
